| Literature DB >> 32618271 |
Malgorzata Broncel1, Caia Dominicus1, Luis Vigetti2, Stephanie D Nofal1, Edward J Bartlett3, Bastien Touquet2, Alex Hunt1, Bethan A Wallbank1, Stefania Federico4, Stephen Matthews5, Joanna C Young1, Edward W Tate3, Isabelle Tardieux2, Moritz Treeck1.
Abstract
N-myristoylation is a ubiquitous class of protein lipidation across eukaryotes and N-myristoyl transferase (NMT) has been proposed as an attractive drug target in several pathogens. Myristoylation often primes for subsequent palmitoylation and stable membrane attachment, however, growing evidence suggests additional regulatory roles for myristoylation on proteins. Here we describe the myristoylated proteome of Toxoplasma gondii using chemoproteomic methods and show that a small-molecule NMT inhibitor developed against related Plasmodium spp. is also functional in Toxoplasma. We identify myristoylation on a transmembrane protein, the microneme protein 7 (MIC7), which enters the secretory pathway in an unconventional fashion with the myristoylated N-terminus facing the lumen of the micronemes. MIC7 and its myristoylation play a crucial role in the initial steps of invasion, likely during the interaction with and penetration of the host cell. Myristoylation of secreted eukaryotic proteins represents a substantial expansion of the functional repertoire of this co-translational modification.Entities:
Keywords: host cell invasion; infectious disease; microbiology; myristoylation; proteomics; toxoplasma
Mesh:
Substances:
Year: 2020 PMID: 32618271 PMCID: PMC7373427 DOI: 10.7554/eLife.57861
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140